NASDAQ: NVCR NovoCure Ltd 8-K

NovoCure appoints Uri Weinberg as Chief Medical Officer, adds CHF 5,000 monthly salary

Filed April 9, 2026 · Period ending April 8, 2026 · ~1 min read

Key Changes

  • medium

    Dr. Uri Weinberg appointed Chief Medical Officer while retaining Chief Innovation Officer role, consolidating medical and innovation leadership under one executive.

  • low

    Weinberg's monthly salary increased by CHF 5,000 (approximately $5,600 USD) for duration of CMO role, effective April 8, 2026.

    Weinberg Letter Agreement verify on EDGAR →

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade NVCR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 6:09 PM